Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism
NCT05924620
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Primary Aldosteronism
Interventions
DRUG:
finerenone
Sponsor
Chongqing Medical University